Back to search

Belgium· BE-AMP-SAM468506-00

Trulicity 0.75 mg

A dulaglutide product containing dulaglutide, registered in Belgium by Eli Lilly Nederland. The same ATC class is registered in 14 of our 19 countries.

ATC A10BJ05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTrulicity 0.75 mgATCA10BJ05REGISTER NO.BE-AMP-SAM468506-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Dulaglutide is registered in 14 of 19 countries.

Countries holding a registration under ATC A10BJ05 (dulaglutide), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose

Dulaglutide · ATC A10BJ05

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dulaglutide costs, country by country.

Normalised to the WHO defined daily dose (0.16 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Dulaglutide · price per daily dose (0.16 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$7.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Dulaglutide
Manufacturer
Eli Lilly Nederland
Country
Belgium (BE)
ATC code
A10BJ05
ATC class
Dulaglutide
Defined daily dose
0.16 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    3275971
    EUR 104.05
  • be_apb
    7714900

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

301 interactions on record for dulaglutide.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dulaglutide · interactions on record

301 records

  • 3 severe
  • 257 moderate
  • 41 minor

Most severe, free to view

  • GatifloxacinJ01MA16severe
  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dulaglutide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dulaglutide products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Trulicity
  • Liechtenstein · Trulicity
  • Norway · Trulicity

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9276271f-1719-4f62-b5c4-5d5101ec00dc
GET /v1/drugs/9276271f-1719-4f62-b5c4-5d5101ec00dc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in pre-filled pen",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Trulicity 0.75 mg",
  "name_fr": "Trulicity 0.75 mg",
  "name_nl": "Trulicity 0.75 mg",
  "amp_code": "SAM468506-00",
  "strengths": [
    "1.5000"
  ],
  "pack_count": 3,
  "substances": [
    "Dulaglutide",
    "Mannitol",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Dulaglutide",
  "authorisation_numbers": [
    "EU/1/14/956/001",
    "EU/1/14/956/002",
    "EU/1/14/956/003"
  ]
}

See everything about dulaglutide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.